Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study
Titel:
Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study
Auteur:
Long, Georgina V Dummer, Reinhard Hamid, Omid Gajewski, Thomas F Caglevic, Christian Dalle, Stephane Arance, Ana Carlino, Matteo S Grob, Jean-Jacques Kim, Tae Min Demidov, Lev Robert, Caroline Larkin, James Anderson, James R Maleski, Janet Jones, Mark Diede, Scott J Mitchell, Tara C